Mission Bio, a leader in single-cell multiomics solutions for precision medicine, announced the release of data from scientists at Genentech’s Analytical Development Group, showcasing...
Latigo Biotherapeutics Inc. announced positive Phase 1 results for LTG-001, its lead potential best-in-class non-opioid pain medicine candidate. In a Phase 1 first-in-human clinical...
SalioGen Therapeutics, a biotechnology company developing next-generation genetic medicines based on its novel Gene Coding technology, announced the appointment of Kalliopi "Kali" Stasi, M.D.,...
BerGenBio ASA, a clinical-stage biopharmaceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, announced a collaboration with Tempus, a technology...
MOMA Therapeutics, a clinical-stage biopharmaceutical company discovering and developing a new generation of precision therapeutics, announced that the first patient has been dosed in...
